| 2025-12-12 |
详情>>
内部人交易：
Howell Laura股份增加322.00股
|
| 2025-11-07 |
详情>>
股本变动：
变动后总股本14386.52万股
|
| 2025-11-07 |
详情>>
业绩披露：
2025年三季报(累计)每股收益2.52美元,归母净利润3.67亿美元,同比去年增长0.53%
|
| 2025-11-06 |
财报披露：
美东时间 2025-11-06 盘后发布财报
|
| 2025-08-08 |
详情>>
业绩披露：
2025年中报每股收益1.54美元,归母净利润2.27亿美元,同比去年增长-26.15%
|
| 2025-05-09 |
详情>>
业绩披露：
2025年一季报每股收益0.83美元,归母净利润1.23亿美元,同比去年增长-29.78%
|
| 2025-04-01 |
股东大会：
将于2025-05-14召开股东大会
会议内容 ▼▲
- 1.To elect nine nominees currently serving as members of our Board of Directors and named in the attached proxy statement to serve on our Board of Directors for a one-year term expiring at the 2026 Annual Meeting of Stockholders;
2.To approve an amendment to our Second Amended and Restated 2013 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 8,000,000 shares (“Plan Proposal”);
3.To approve, on an advisory basis, our Named Executive Officer (“NEO”) compensation;
4.To approve amendments to our Amended and Restated Certificate of Incorporation to eliminate the existing supermajority vote requirements for:
5.To adjourn the Annual Meeting to a later date or dates, if necessary, to solicit additional proxies to establish a quorum or if there are insufficient votes to adopt any proposal (other than Proposal 8) (“Adjournment Proposal”);
6.To ratify the selection of PricewaterhouseCoopers LLP as our independent auditors for the fiscal year ending December 31, 2025;
7.To vote upon an advisory proposal to give shareholders the ability to call a special shareholder meeting (the “Company Special Meeting Proposal”);
8.To vote upon a shareholder proposal to give shareholders the ability to call a special shareholder meeting, if properly presented at the Annual Meeting (the “Shareholder Special Meeting Proposal”);
9.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2025-02-24 |
详情>>
业绩披露：
2024年年报每股收益3.34美元,归母净利润5.05亿美元,同比去年增长-7.8%
|
| 2025-02-24 |
详情>>
业绩披露：
2022年年报每股收益3.29美元,归母净利润5.24亿美元,同比去年增长-19.64%
|
| 2024-11-08 |
详情>>
业绩披露：
2024年三季报(累计)每股收益2.40美元,归母净利润3.65亿美元,同比去年增长-5.55%
|
| 2024-08-08 |
详情>>
业绩披露：
2023年中报每股收益1.47美元,归母净利润2.26亿美元,同比去年增长-16.7%
|
| 2024-08-08 |
详情>>
业绩披露：
2024年中报每股收益2.02美元,归母净利润3.07亿美元,同比去年增长35.93%
|
| 2024-05-09 |
详情>>
业绩披露：
2024年一季报每股收益1.16美元,归母净利润1.75亿美元,同比去年增长80.65%
|
| 2024-03-28 |
股东大会：
将于2024-05-10召开股东大会
会议内容 ▼▲
- 1.To elect ten nominees currently serving as members of our Board of Directors and named in the attached proxy statement to serve on our Board of Directors for a one-year term expiring at the 2025 Annual Meeting of Stockholders;
2.To approve an amendment to our Second Amended and Restated 2013 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 5,000,000 shares (“Plan Proposal”);
3.To approve, on an advisory basis, our named executive officer compensation;
4.To approve our Amended and Restated Certificate of Incorporation to limit the liability of certain officers as permitted by recent amendments to Delaware law and certain additional clarifying changes (the “Exculpation Proposal”);
5.To adjourn the Annual Meeting to a later date or dates, if necessary, to solicit additional proxies to establish a quorum or if there are insufficient votes to adopt any proposal (other than Proposal 7) (“Adjournment Proposal”);
6.To ratify the selection of PricewaterhouseCoopers LLP as our independent auditors for the fiscal year ending December 31, 2024;
7.To vote upon a shareholder proposal regarding a simple majority vote, if properly presented at the Annual Meeting;
8.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2024-02-28 |
详情>>
业绩披露：
2023年年报每股收益3.59美元,归母净利润5.48亿美元,同比去年增长4.57%
|
| 2023-11-08 |
详情>>
业绩披露：
2023年三季报(累计)每股收益2.53美元,归母净利润3.86亿美元,同比去年增长-2.14%
|
| 2023-03-29 |
股东大会：
将于2023-05-11召开股东大会
会议内容 ▼▲
- 1.To elect ten nominees currently serving as members of our Board of Directors and named in the attached proxy statement to serve on our Board of Directors for a one-year term expiring at the 2024 Annual Meeting of Stockholders;
2.To approve an amendment to our Second Amended and Restated 2013 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 7,250,000 shares;
3.To approve, on an advisory basis, our named executive officer compensation;
4.To vote, on an advisory basis, on the frequency of future advisory votes on named executive officer compensation;
5.To ratify the selection of PricewaterhouseCoopers LLP as our independent auditors for the fiscal year ending December 31, 2023;
6.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2023-03-29 |
股东大会：
将于2023-05-11召开股东大会
会议内容 ▼▲
- 1.To elect ten nominees currently serving as members of our Board of Directors and named in the attached proxy statement to serve on our Board of Directors for a one-year term expiring at the 2024 Annual Meeting of Stockholders;
2.To approve an amendment to our Second Amended and Restated 2013 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 7,250,000 shares;
3.To approve, on an advisory basis, our named executive officer compensation;
4.To vote, on an advisory basis, on the frequency of future advisory votes on named executive officer compensation;
5.To ratify the selection of PricewaterhouseCoopers LLP as our independent auditors for the fiscal year ending December 31, 2023;
6.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2022-03-30 |
股东大会：
将于2022-05-12召开股东大会
会议内容 ▼▲
- 1.To elect ten nominees currently serving as members of our Board of Directors and named in the attached proxy statement to serve on our Board of Directors for a one-year term expiring at the 2023 Annual Meeting of Stockholders;
2.To approve an amendment and restatement of our Amended and Restated 2013 Stock Incentive Plan (the “Plan”) to, among other things, (i) increase the number of shares of common stock authorized for issuance thereunder by 2,000,000 shares, (ii) address the treatment of time- and performance-based equity awards under the Plan upon a change in control event, (iii) remove certain provisions related to Section 162(m) of the Internal Revenue Code of 1986, as amended, that are no longer relevant as a result of the elimination of the exemption for qualified performance-based compensation under Section 162(m) and (iv) extend the expiration date of the Plan to May 12, 2032;
3.To approve, on an advisory basis, our named executive officer compensation;
4.To ratify the selection of PricewaterhouseCoopers LLP as our independent auditors for the fiscal year ending December 31, 2022;
5.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-23 |
股东大会：
将于2021-06-03召开股东大会
会议内容 ▼▲
- 1.To elect eleven nominees currently serving as members of our Board of Directors and named in the attached proxy statement to serve on our Board of Directors for a one-year term expiring at the 2022 Annual Meeting of Stockholders;
2.To approve an amendment and restatement of our 2013 Stock Incentive Plan that will include (i) a 3,000,000 share increase in the number of shares of common stock authorized for issuance thereunder and (ii) an extension of the expiration date of the plan to June 3, 2031;
3.To approve, on an advisory basis, our named executive officer compensation;
4.To ratify the selection of PricewaterhouseCoopers LLP as our independent auditors for the fiscal year ending December 31, 2021;
5.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2020-04-09 |
股东大会：
将于2020-05-20召开股东大会
会议内容 ▼▲
- 1.To elect three nominees currently serving as Class II members of our Board of Directors and four nominees currently serving as Class III members of our Board of Directors, each as named in the attached proxy statement, to each serve on our Board of Directors for a one-year term expiring at the 2021 Annual Meeting of Stockholders;
2.To approve, on an advisory basis, our named executive officer compensation;
3.To ratify the selection of PricewaterhouseCoopers LLP as our independent auditors for the fiscal year ending December 31, 2020;
4.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2019-04-02 |
股东大会：
将于2019-05-15召开股东大会
会议内容 ▼▲
- 1.To elect the three nominees named in the attached proxy statement as members of our Board of Directors to serve as Class II directors for a one-year term;
2.To approve amendments to our 2013 Stock Incentive Plan to (i) increase the number of shares of common stock authorized for issuance thereunder from 18,500,000 shares to 21,500,000 shares and (ii) provide additional limits on annual non-employee director compensation;
3.To approve, on an advisory basis, our named executive officer compensation;
4.To ratify the selection of PricewaterhouseCoopers LLP as our independent auditors for the fiscal year ending December 31, 2019;
5.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2018-04-20 |
股东大会：
将于2018-06-01召开股东大会
会议内容 ▼▲
- (1)To elect the four nominees named in the attached proxy statement as members of our Board of Directors to serve as Class I directors for a term of three years;
(2)To adopt and approve amendments to our Certificate of Incorporation to declassify our Board of Directors;
(3)To approve, on an advisory basis, our named executive officer compensation;
(4)To ratify the selection of PricewaterhouseCoopers LLP as our independent auditors for the fiscal year ending December 31, 2018;
(5)To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2017-04-03 |
股东大会：
将于2017-05-17召开股东大会
会议内容 ▼▲
- (1)To elect the three nominees named in the attached proxy statement as members of our Board of Directors to serve as Class III directors for a term of three years;
(2)To approve amendments to increase the number of shares of common stock authorized for issuance under Akamai’s 2013 Stock Incentive Plan from 11,000,000 shares to 18,500,000 shares and to certain other provisions of such plan;
(3)To approve, on an advisory basis, our named executive officer compensation;
(4)To approve, on an advisory basis, the frequency of future advisory votes on named executive officer compensation;
(5)To ratify the selection of PricewaterhouseCoopers LLP as our independent auditors for the fiscal year ending December 31, 2017;
(6)To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2016-03-31 |
股东大会：
将于2016-05-11召开股东大会
会议内容 ▼▲
- 1.To elect the four nominees named in the attached proxy statement as members of our Board of Directors to serve as Class II directors for a term of three years;
2.To approve, on an advisory basis, our executive officer compensation;
3.To ratify the selection of PricewaterhouseCoopers LLP as our independent auditors for the fiscal year ending December 31, 2016;
4.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|